advertisement

WGC-2021

11.13.2 Betablocker and carbon anhydrase inhibitor (10)

Showing records 1 to 10

Display all abstracts in classification 11.13.2 Betablocker and carbon anhydrase inhibitor

Search within classification 11.13.2 Betablocker and carbon anhydrase inhibitor
91148 Can dorzolamide/timolol-fixed combination effectively treat primary open-angle glaucoma?: A protocol for systematic review and meta-analysis
Qi YX
Medicine 2020; 99: e23245
91764 Dorzolamide/Timolol Fixed Combination: Learning from the Past and Looking Toward the Future
Konstas AG
Advances in Therapy 2021; 38: 24-51
91148 Can dorzolamide/timolol-fixed combination effectively treat primary open-angle glaucoma?: A protocol for systematic review and meta-analysis
Liu HW
Medicine 2020; 99: e23245
91764 Dorzolamide/Timolol Fixed Combination: Learning from the Past and Looking Toward the Future
Schmetterer L
Advances in Therapy 2021; 38: 24-51
91148 Can dorzolamide/timolol-fixed combination effectively treat primary open-angle glaucoma?: A protocol for systematic review and meta-analysis
Sun Q
Medicine 2020; 99: e23245
91764 Dorzolamide/Timolol Fixed Combination: Learning from the Past and Looking Toward the Future
Katsanos A; Hutnik CML
Advances in Therapy 2021; 38: 24-51
91148 Can dorzolamide/timolol-fixed combination effectively treat primary open-angle glaucoma?: A protocol for systematic review and meta-analysis
Su XJ
Medicine 2020; 99: e23245
91764 Dorzolamide/Timolol Fixed Combination: Learning from the Past and Looking Toward the Future
Holló G
Advances in Therapy 2021; 38: 24-51
91148 Can dorzolamide/timolol-fixed combination effectively treat primary open-angle glaucoma?: A protocol for systematic review and meta-analysis
Han L
Medicine 2020; 99: e23245
91764 Dorzolamide/Timolol Fixed Combination: Learning from the Past and Looking Toward the Future
Quaranta L; Teus MA; Uusitalo H; Pfeiffer N; Katz LJ
Advances in Therapy 2021; 38: 24-51

Issue 21-4

Change Issue


advertisement

WGC-2021